Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1970 1
1977 1
1978 1
1979 1
1980 2
1982 3
1983 1
1984 3
1985 4
1986 3
1987 6
1988 2
1989 4
1990 8
1991 7
1992 8
1993 4
1994 2
1995 12
1996 8
1997 10
1998 12
1999 10
2000 10
2001 3
2002 17
2003 10
2004 12
2005 16
2006 16
2007 11
2008 13
2009 12
2010 10
2011 13
2012 7
2013 11
2014 8
2015 4
2016 2
2017 7
2018 3
2019 3
2020 3
2021 1
2022 1
2023 0

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 15865103

293 results

Results by year

Filters applied: . Clear all
Page 1
Temozolomide and cisplatin in avdanced malignant melanoma.
Daponte A, Ascierto PA, Gravina A, Melucci M, Scala S, Ottaiano A, Simeone E, Palmieris G, Comella G. Daponte A, et al. Anticancer Res. 2005 Mar-Apr;25(2B):1441-7. Anticancer Res. 2005. PMID: 15865103 Free article. Clinical Trial.
Temozolomide and cisplatin versus temozolomide in patients with advanced melanoma: a randomized phase II study of the Hellenic Cooperative Oncology Group.
Bafaloukos D, Tsoutsos D, Kalofonos H, Chalkidou S, Panagiotou P, Linardou E, Briassoulis E, Efstathiou E, Polyzos A, Fountzilas G, Christodoulou C, Kouroussis C, Iconomou T, Gogas H. Bafaloukos D, et al. Ann Oncol. 2005 Jun;16(6):950-7. doi: 10.1093/annonc/mdi190. Epub 2005 Apr 13. Ann Oncol. 2005. PMID: 15829494 Free article. Clinical Trial.
Phase II trial of subcutaneous interleukin-2, subcutaneous interferon-alpha, intravenous combination chemotherapy, and oral tamoxifen in the treatment of metastatic melanoma: final results of cancer biotherapy research group 94-11.
Dillman RO, Soori G, Wiemann MC, Schulof R, Dobbs TW, Ruben RH, DePriest CB, Church C. Dillman RO, et al. Cancer Biother Radiopharm. 2000 Oct;15(5):487-94. doi: 10.1089/cbr.2000.15.487. Cancer Biother Radiopharm. 2000. PMID: 11155820 Clinical Trial.
293 results